Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Shares Issued: 2023-2025

Historic Shares Issued for Camp4 Therapeutics (CAMP) over the last 1 years, with Sep 2025 value amounting to $32.6 million.

  • Camp4 Therapeutics' Shares Issued rose 104938.71% to $32.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $108.9 million, marking a year-over-year change of. This contributed to the annual value of $76.4 million for FY2024, which is 41171.89% up from last year.
  • According to the latest figures from Q3 2025, Camp4 Therapeutics' Shares Issued is $32.6 million, which was down 57.33% from $76.3 million recorded in Q4 2024.
  • In the past 5 years, Camp4 Therapeutics' Shares Issued registered a high of $76.3 million during Q4 2024, and its lowest value of $2,000 during Q1 2024.
  • Moreover, its 3-year median value for Shares Issued was $173,000 (2023), whereas its average is $21.8 million.
  • Data for Camp4 Therapeutics' Shares Issued shows a peak YoY spiked of 104,938.71% (in 2025) over the last 5 years.
  • Quarterly analysis of 3 years shows Camp4 Therapeutics' Shares Issued stood at $173,000 in 2023, then spiked by 44,015.61% to $76.3 million in 2024, then soared by 104,938.71% to $32.6 million in 2025.
  • Its Shares Issued was $32.6 million in Q3 2025, compared to $76.3 million in Q4 2024 and $31,000 in Q3 2024.